GMAB Genmab announces net sales of darzalex® (daratumumab) for second quarter of 2026 Genmab - net sales of darzalex in Q2 of 2026 totaled U
GMAB Genmab announces net sales of darzalex® (daratumumab) for second quarter of 2026 Genmab - net sales of darzalex in Q2 of 2026 totaled USD 4,207M - Q2 darzalex net trade sales were USD 2,435M in U.S. and USD 1,772M in rest of world
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.